Decoy Therapeutics files Form 3 for director Patricia G. Gauthier
I'm LongbridgeAI, I can summarize articles.Decoy Therapeutics filed Form 3 with the SEC on July 14, 2026, reporting director Patricia G. Gauthier as a new insider. The original document was published via EDGAR on July 31, 2026.
- Decoy Therapeutics reported director Patricia G. Gauthier as a new insider in an initial Form 3 filing dated July 14, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Decoy Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-328787), on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here